- Home
- AXSM vs MAIN Comparison
AXSM vs MAIN Comparison
Compare AXSM & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- MAIN
- Stock Information
- Founded
- AXSM 2012
- MAIN 2007
- Country
- AXSM United States
- MAIN United States
- Employees
- AXSM N/A
- MAIN N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- MAIN Finance/Investors Services
- Sector
- AXSM Health Care
- MAIN Finance
- Exchange
- AXSM Nasdaq
- MAIN Nasdaq
- Market Cap
- AXSM 4.7B
- MAIN 4.5B
- IPO Year
- AXSM 2015
- MAIN 2007
- Fundamental
- Price
- AXSM $90.73
- MAIN $56.42
- Analyst Decision
- AXSM Strong Buy
- MAIN Hold
- Analyst Count
- AXSM 14
- MAIN 5
- Target Price
- AXSM $125.93
- MAIN $48.80
- AVG Volume (30 Days)
- AXSM 499.7K
- MAIN 368.8K
- Earning Date
- AXSM 02-18-2025
- MAIN 02-20-2025
- Dividend Yield
- AXSM N/A
- MAIN 7.45%
- EPS Growth
- AXSM N/A
- MAIN 11.78
- EPS
- AXSM N/A
- MAIN 5.51
- Revenue
- AXSM $338,457,000.00
- MAIN $529,897,000.00
- Revenue This Year
- AXSM $44.89
- MAIN $10.58
- Revenue Next Year
- AXSM $68.41
- MAIN $5.22
- P/E Ratio
- AXSM N/A
- MAIN $10.23
- Revenue Growth
- AXSM 51.47
- MAIN 9.27
- 52 Week Low
- AXSM $64.11
- MAIN $42.68
- 52 Week High
- AXSM $105.00
- MAIN $56.87
- Technical
- Relative Strength Index (RSI)
- AXSM 42.16
- MAIN 71.31
- Support Level
- AXSM $89.09
- MAIN $54.96
- Resistance Level
- AXSM $94.64
- MAIN $56.55
- Average True Range (ATR)
- AXSM 3.64
- MAIN 0.74
- MACD
- AXSM -1.14
- MAIN -0.04
- Stochastic Oscillator
- AXSM 20.64
- MAIN 80.01
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About MAIN Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing's, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.